falsefalse

Key Data from the CYTO-PV and MAJIC-PV Studies: Evaluating Ruxolitinib in Polycythemia Vera

Dr. Pankit Vachhani presents key data from the CYTO-PV and MAJIC-PV studies, evaluating the efficacy of ruxolitinib versus best available therapy in patients with polycythemia vera, focusing on clinical outcomes such as cardiovascular risk reduction, hematocrit management, and long-term molecular responses.

Video Player is loading.
Current Time 0:00
Duration 15:58
Loaded: 0%
Stream Type LIVE
Remaining Time 15:58
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

x